2190 — Zylox-Tonbridge Medical Technology Co Balance Sheet
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMid CapSucker Stock
- HK$6.74bn
- HK$3.35bn
- CNY177.91m
Annual balance sheet for Zylox-Tonbridge Medical Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Cash | |||
| Short Term Investments | |||
| Cash and Short Term Investments | 98.1 | 317 | 2,929 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | 8.74 | 6.5 | 5.33 |
| Total Inventory | |||
| Prepaid Expenses | |||
| Total Other Current Assets | |||
| Total Current Assets | 125 | 370 | 3,024 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | 70.7 | 122 | 212 |
| Net Intangible Assets | |||
| Other Long Term Assets | |||
| Total Assets | 207 | 504 | 3,248 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 33.4 | 51.6 | 97.1 |
| Long Term Debt | |||
| Capital Lease Obligations | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Liabilities | 41.4 | 79.3 | 104 |
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Treasury Stock | |||
| ESOP Debt Guarantee | |||
| Other Equity | |||
| Total Equity | 166 | 425 | 3,145 |
| Total Liabilities & Shareholders' Equity | 207 | 504 | 3,248 |
| Total Common Shares Outstanding |